Clinical Trial Update: Oral Prednisolone to Prevent Esophageal Stricture After RFA for Long-segment Esophageal Neoplasia [Phase 4]

View source ↗

Summary

Phase 4 trial investigating oral prednisolone to prevent esophageal stricture after radiofrequency ablation for long-segment esophageal neoplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Neoplasms
• Esophageal Stricture

Drugs mentioned

• Prednisolone (Prednisolone)

Snippet

Sponsor: E-DA Hospital | Conditions: Esophageal Neoplasms, Esophagus Stenosis | Phase 4 | Status: UNKNOWN